Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

365 ARTÍCULOS , VIENDO DEL 16 AL 30

Phytochemicals in the Treatment of Alzheimer's Disease: A Systematic Review

D'Onofrio G, Sancarlo D, Ruan Q, Yu Z, Panza F, Daniele A, Greco A, Seripa D.

Curr Drug Targets. 2017;18(13):1487-1498. doi: 10.2174/1389450117666161102121553.

Protective Effects of Caffeic Acid and the Alzheimer's Brain: An Update

Habtemariam S.

Mini Rev Med Chem. 2017;17(8):667-674. doi: 10.2174/1389557516666161130100947.

Research update on Alzheimer's disease and introduction to the Expert Review of Neurotherapeutics special issue

Gauthier S.

Expert Rev Neurother. 2017 Jan;17(1):1-2. doi: 10.1080/14737175.2017.1268054.

Serotonin 5-HT(6) Receptor Antagonists in Alzheimer's Disease: Therapeutic Rationale and Current Development Status

Ferrero H, Solas M, Francis PT, Ramirez MJ.

CNS Drugs. 2017 Jan;31(1):19-32. doi: 10.1007/s40263-016-0399-3.

Deep Brain Stimulation for Alzheimer's Disease: Ethical Challenges for Clinical Research

Siegel AM, Barrett MS, Bhati MT.

J Alzheimers Dis. 2017;56(2):429-439. doi: 10.3233/JAD-160356.

Targeted Nanoparticles for the Treatment of Alzheimer's Disease

Martín-Rapun R, De Matteis L, Ambrosone A, Garcia-Embid S, Gutierrez L, de la Fuente JM.

Curr Pharm Des. 2017;23(13):1927-1952. doi: 10.2174/1381612822666161226151011.

Modulators of IgG penetration through the blood-brain barrier: Implications for Alzheimer's disease immunotherapy

Finke JM, Banks WA.

Hum Antibodies. 2017;25(3-4):131-146. doi: 10.3233/HAB-160306.

The Citicholinage Study: Citicoline Plus Cholinesterase Inhibitors in Aged Patients Affected with Alzheimer's Disease Study

Gareri P, Castagna A, Cotroneo AM, Putignano D, Conforti R, Santamaria F, Marino S, Putignano S.

J Alzheimers Dis. 2017;56(2):557-565. doi: 10.3233/JAD-160808.

Editorial: Multitarget Molecules for Alzheimer's Disease Therapy

Marco-Contelles J, Fall Y.

Curr Top Med Chem. 2017;17(31):3318. doi: 10.2174/156802661731180221110409.

Rationally Designed Peptides and Peptidomimetics as Inhibitors of Amyloid-β (Aβ) Aggregation: Potential Therapeutics of Alzheimer's Disease

Goyal D, Shuaib S, Mann S, Goyal B.

ACS Comb Sci. 2017 Feb 13;19(2):55-80. doi: 10.1021/acscombsci.6b00116. Epub 2017 Jan 18.

Alzheimer, organiser une prise en charge globale

Trochet C.

Rev Infirm. 2017 Jan;66(227):15. doi: 10.1016/j.revinf.2016.11.002.

Elucidating Treatment of Alzheimer's Disease via Different Receptors

Ul Islam B, Khan MS, Jabir NR, Kamal MA, Tabrez S.

Curr Top Med Chem. 2017;17(12):1400-1407. doi: 10.2174/1568026617666170103163715.

Alzheimer's Disease and Natural Products: Future Regimens Emerging from Nature

Islam MA, Khandker SS, Alam F, Khalil MI, Kamal MA, Gan SH.

Curr Top Med Chem. 2017;17(12):1408-1428. doi: 10.2174/1568026617666170103163054.

Antibody Therapeutics Targeting Aβ and Tau

Gallardo G, Holtzman DM.

Cold Spring Harb Perspect Med. 2017 Oct 3;7(10):a024331. doi: 10.1101/cshperspect.a024331.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias